Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collplant Biotechnologies Ltd ADR (CLGN)

Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,887
  • Shares Outstanding, K 14,415
  • Annual Sales, $ 2,370 K
  • Annual Income, $ -11,490 K
  • EBIT $ -11 M
  • EBITDA $ -11 M
  • 60-Month Beta 2.75
  • Price/Sales 2.18
  • Price/Cash Flow N/A
  • Price/Book 0.75
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.35
  • Most Recent Earnings $-0.67 on 03/26/26
  • Next Earnings Date 05/27/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 249.16% (-519.86%)
  • Historical Volatility 112.53%
  • IV Percentile 48%
  • IV Rank 20.54%
  • IV High 944.80% on 10/27/25
  • IV Low 69.34% on 09/19/25
  • Expected Move (DTE 8) 1.9125 (563.83%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 153
  • Open Int (30-Day) 147
  • Expected Range 0.0000 to 2.2517

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.34
  • Growth Rate Est. (year over year) +293,923.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3173 +7.15%
on 04/08/26
0.8500 -60.00%
on 03/26/26
-0.2900 (-46.03%)
since 03/09/26
3-Month
0.3173 +7.15%
on 04/08/26
1.9900 -82.91%
on 01/28/26
-1.1300 (-76.87%)
since 01/09/26
52-Week
0.3173 +7.15%
on 04/08/26
4.9800 -93.17%
on 05/29/25
-2.1600 (-86.40%)
since 04/09/25

Most Recent Stories

More News
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

REHOVOT, Israel , March 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on...

CLGN : 0.3450 (+1.77%)
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

REHOVOT, Israel , March 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...

CLGN : 0.3450 (+1.77%)
CollPlant Biotechnologies Launches Redesigned Corporate Website

REHOVOT, Israel , March 18, 2026 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary...

CLGN : 0.3450 (+1.77%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS

REHOVOT, Israel , March 11, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

CLGN : 0.3450 (+1.77%)
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler

REHOVOT, Israel , Feb. 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on...

CLGN : 0.3450 (+1.77%)
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex

REHOVOT, Israel , Feb. 23, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary...

CLGN : 0.3450 (+1.77%)
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments

Next-generation rhCollagen-based technology aims to restore facial structure and skin quality in patients experiencing volume depletion linked to GLP-1 weight-loss therapies

CLGN : 0.3450 (+1.77%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING

REHOVOT, Israel , Feb. 5, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.3450 (+1.77%)
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

REHOVOT, Israel , Nov. 26, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.3450 (+1.77%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

REHOVOT, Israel , Nov. 18, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.3450 (+1.77%)

Business Summary

CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw...

See More

Key Turning Points

3rd Resistance Point 0.4529
2nd Resistance Point 0.4215
1st Resistance Point 0.3802
Last Price 0.3450
1st Support Level 0.3075
2nd Support Level 0.2761
3rd Support Level 0.2348

See More

52-Week High 4.9800
Fibonacci 61.8% 3.1988
Fibonacci 50% 2.6486
Fibonacci 38.2% 2.0985
Last Price 0.3450
52-Week Low 0.3173

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.